Hide metadata

dc.date.accessioned2023-02-28T18:04:49Z
dc.date.available2023-02-28T18:04:49Z
dc.date.created2023-01-04T13:08:57Z
dc.date.issued2022
dc.identifier.citationLee, G.A. Aktaa, S. Baker, E. Gale, C.P. Yaseen, Israa F. Gulati, Geeta Asteggiano, R. Szmit, S. Cohen-Solal, A. Abdin, A. Jurczak, W. Lopez, P. Garrido Sverdlov, A.L. Tocchetti, C.G. Barac, A. Parrini, I. Zamorano, P. Iakobishvili, Z. Pudil, R. Badimon, L. Kirby, A.M. Blaes, A.H. Farmakis, D. Curigliano, G. Stephens, R. Lyon, A.R. Lopez-Fernandez, T. . European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment. European Heart Journal - Quality of Care and Clinical Outcomes. 2022, 9(1), 1-7
dc.identifier.urihttp://hdl.handle.net/10852/100493
dc.description.abstractAbstract Aims To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. Methods and results We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. Work was undertaken in parallel with the writing of the 2022 ESC Guidelines on Cardio-Oncology and in collaboration with the European Haematology Association, the European Society for Therapeutic Radiology and Oncology and the International Cardio-Oncology Society. In total, 5 main and 9 secondary QIs were selected across five domains of care: (i) Structural framework, (ii) Baseline cardiovascular risk assessment, (iii) Cancer therapy related cardiovascular toxicity, (iv) Predictors of outcomes, and (v) Monitoring of cardiovascular complications during cancer therapy. Conclusion We present the ESC Cardio-Oncology QIs with their development process and provide an overview of the scientific rationale for their selection. These indicators are aimed at quantifying and improving the adherence to guideline-recommended clinical practice and improving patient outcomes.
dc.languageEN
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleEuropean Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
dc.title.alternativeENEngelskEnglishEuropean Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
dc.typeJournal article
dc.creator.authorLee, G.A.
dc.creator.authorAktaa, S.
dc.creator.authorBaker, E.
dc.creator.authorGale, C.P.
dc.creator.authorYaseen, Israa F.
dc.creator.authorGulati, Geeta
dc.creator.authorAsteggiano, R.
dc.creator.authorSzmit, S.
dc.creator.authorCohen-Solal, A.
dc.creator.authorAbdin, A.
dc.creator.authorJurczak, W.
dc.creator.authorLopez, P. Garrido
dc.creator.authorSverdlov, A.L.
dc.creator.authorTocchetti, C.G.
dc.creator.authorBarac, A.
dc.creator.authorParrini, I.
dc.creator.authorZamorano, P.
dc.creator.authorIakobishvili, Z.
dc.creator.authorPudil, R.
dc.creator.authorBadimon, L.
dc.creator.authorKirby, A.M.
dc.creator.authorBlaes, A.H.
dc.creator.authorFarmakis, D.
dc.creator.authorCurigliano, G.
dc.creator.authorStephens, R.
dc.creator.authorLyon, A.R.
dc.creator.authorLopez-Fernandez, T.
cristin.unitcode185,53,82,0
cristin.unitnameKlinikk for indremedisin og lab fag
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2100505
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=European Heart Journal - Quality of Care and Clinical Outcomes&rft.volume=9&rft.spage=1&rft.date=2022
dc.identifier.jtitleEuropean Heart Journal - Quality of Care and Clinical Outcomes
dc.identifier.volume9
dc.identifier.issue1
dc.identifier.startpage1
dc.identifier.endpage7
dc.identifier.doihttps://doi.org/10.1093/ehjqcco/qcac070
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2058-5225
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial 4.0 International
This item's license is: Attribution-NonCommercial 4.0 International